Due to their feelings of fear and guilt regarding the effect of diabetes on their baby, participants with both type 1 and type 2 diabetes described the need to control their diabetes management as much as possible, including bargaining with physicians and healthcare providers to remain on the devices (i.e., insulin pumps) that give women autonomy and control of their diabetes management.“I had, you know built up the courage 'cause you're like, ‘I'm gonna tell this doctor how I want things done’ and so I was like ‘I want to be in charge. The gene discussed is INS; the disease is type 2 diabetes mellitus.